BridgeMD
Compares treatment options for Sedation for Diagnostic Gastroscopy
Official title Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06614036
What this study is testing
What is Remimazolam?
Remimazolam is an investigational medicine, given as an once-daily injectable medicine, being studied as a potential treatment for sedation for diagnostic gastroscopy.
Also referred to as Midazolam.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Rationale Midazolam is known for its safety, effectiveness for procedural sedation during gastrointestinal (GI) endoscopy and is used as standard sedative by endoscopists worldwide. Remimazolam is a novel, recently approved sedative, with the potential to facilitate a faster (neuropsychiatric) recovery.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients age ≥ 18 years.
- Scheduled for a diagnostic upper GI endoscopy with procedural sedation.
- Ability to provide written informed consent, and to understand the responsibilities of trial participation.
You likely can't join if
- Anticipated use of opioids, such as a therapeutic endoscopy or any other reason.
- ASA score of 4.
- Subject has a known history of unresolved drug or alcohol dependency that would limit ability to comprehend or follow instructions related to...
The study team makes the final eligibility decision.
Where it's taking place
- Apeldoorn, Gelderland, Netherlands
- Arnhem, Gelderland, Netherlands
- Nieuwegein, Utrecht, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Apeldoorn, Gelderland, Netherlands; Arnhem, Gelderland, Netherlands; Nieuwegein, Utrecht, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.